Portal vein thrombosis and survival in patients with cirrhosis

Liver Transplantation

Volumn 16, Issue 1, 2010, Pages 83-90

  Englesbe, Michael J ^a   Kubus, James ^a   Muhammad, Wajee ^a   Sonnenday, Christopher J ^a   Welling, Theodore ^a   Punch, Jeffrey D ^a   Lynch, Raymond J ^a   Marrero, Jorge A ^a   Pelletier, Shawn J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXPOSURE VARIABLE; FEMALE; HAZARD RATIO; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL;

ADULT; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MICHIGAN; MIDDLE AGED; PORTAL VEIN; VENOUS THROMBOSIS; WAITING LISTS;

EID: 73949146395     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21941     Document Type: Article

References (15)

1. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004;40:736-741.
2. Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol 2007;7:34.
3. Molmenti EP, Roodhouse TW, Molmenti H, Jaiswal K, Jung G, Marubashi S, et al. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg 2002;235:292-296.
4. Denninger MH, Cha?̈t Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587-591.
5. Gayowski TJ, Marino IR, Doyle HR, Echeverri L, Mieles L, Todo S, et al. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 1996;60:333-338.
6. Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001;49:720-724.
7. Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006;12:2115-2119.
8. Gerbes AL. The patient with refractory ascites. Best Pract Res Clin Gastroenterol 2007;21:551-560.
9. Valla DC, Condat B, Lebrec D. Spectrum of portal vein thrombosis in the West. J Gastroenterol Hepatol 2002; 17(suppl 3):S224-S227.
10. Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000;32:865-871.
11. Bureau C, Vinel JP. Management of failures of first line treatments. Dig Liver Dis 2008;40:343-347.
12. Wong F. The use of TIPS in chronic liver disease. Ann Hepatol 2006;5:5-15.
13. Villanueva C, Miñana J, Ortiz J, Gallego A, Soriano G, Torras X, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001; 345:647-655.
14. Villanueva C, López-Balaguer JM, Aracil C, Kolle L, González B, Miñana J, et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol 2004;40: 757-765.
15. Scientific registry of transplant recipients. Statistical model for 1 year patient survival following liver transplantation in the United States. Available at: http://www.us-transplant. org. Accessed August 2009.